PIK3CD and cancer: Among these molecules, phosphatidylinositol 4,5-bisphosphate 3-kinase (PI3K) is currently being explored and the data achieved so far for this protein and its associated network have already translated into novel targeted therapies in the quest for cancer-treatment strategies [2,3].